The State Duma adopts the government-proposed bill on the mode for entering drugs into civilian circulation. According to the approved bill, manufacturers imported the medications into the Russian market by submitting quality data to Roszdravnadzor or receiving a relevant permit for immunobiological preparations.
The Russian Federation Council terminates the mandatory certification and declaration procedures necessary to produce medicines in Russia. Except for immunobiological medicinal products, each set of a therapeutic product that manufactured in the Russian Federation before placing into production, the manufacturer submits to Roszdravnadzor a report verifying the medicinal product quality and its compliance with the needs established during its state registration.
Russian pharmacies are selling the drugs to counter a migraine at faster rates. About 490.9 thousand migraine medicine packs worth 121.9 million rubles were sold in May 2018. An increase of 3.1% and 1.3% is seen in real and value terms respectively as compared to May 2017. In just one month, a 0.5% increase was noticed in one package weighted average cost of 248.3 rubles.
According to the Russian information agency and publishers Remedium, the ARIA (All-Russian Union of Insurers) along with MHIF (Federal Compulsory Medical Insurance Fund) agreed to strengthen the health care system of Russia. The primary agenda of the collaboration will be the implementation of obligatory health insurance to improve the expertise of healthcare set-up.
Recently, the changes of the resolution #633 by the Russian Government coordinated Russian medical device registration requirements with Eurasian regulations. It also focused to clarify the In vitro diagnostic (IVD) and MD approval methodology.
- 1 of 2